We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Accurately Identifies Patients Who Could Require Emergency Hospital Admission

By HospiMedica International staff writers
Posted on 24 Oct 2024

Emergency admissions (EA), where patients require urgent in-hospital care, pose a significant challenge for healthcare systems. More...

Developing risk prediction models can help alleviate this issue by aiding primary care interventions and public health planning. Researchers have now utilized machine learning to create an update for a tool designed to identify individuals at high risk of requiring urgent hospital care within the next 12 months.

The SPARRAv4 – Scottish Patients At Risk of Readmission and Admission – is an algorithm that predicts the risk of EA within the next 12 months. SPARRA was developed using Scotland’s electronic health records (EHR) databases and has been used since 2006 in the country. The current version of the algorithm (SPARRAv3) was implemented in 2012/13 and is calculated monthly by Public Health Scotland (PHS) for nearly the entire Scottish population. General practitioners (GPs) can access individual-level SPARRA scores to help them devise mitigation strategies for patients with complex care needs. Additionally, aggregate SPARRA scores can be utilized to estimate future demand, aiding in planning and resource allocation. SPARRA has also been widely employed in public health research.

A research team that included investigators from The University of Edinburgh (Edinburgh, UK) has updated the SPARRA algorithm to version 4 (SPARRAv4) using contemporary supervised and unsupervised machine learning (ML) methods. They analyzed health records from 4.8 million residents of Scotland, collected between 2013 and 2018 and maintained by PHS. These records included routinely gathered information by healthcare providers, such as patient history, prescription details, and previous hospital admissions. By applying machine learning techniques to this dataset, the researchers developed SPARRAv4 to predict which patients might need emergency hospital care within a 12-month timeframe.

In tests, the team discovered that SPARRAv4 was more effective at identifying emergency admissions compared to the previous version. According to results published in npj Digital Medicine, SPARRAv4 also demonstrated improved accuracy in assessing individual patients’ risk levels for needing urgent hospital care. The researchers assert that the AI-powered update will assist healthcare providers in Scotland in anticipating and planning for emergency cases more effectively while managing healthcare resources more efficiently. They emphasize that although the tool will be a vital aid, it will not replace the critical clinical judgment of medical professionals.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.